EFIZOL 40 tablets - for sore throat
For local antiseptic (antibacterial) treatment of mild inflammatory processes in the oral cavity and nasopharynx, pharyngitis, tonsillitis, laryngitis
- Brand:ACTAVIS
- Code:9992851
PRODUCT INFORMATION
COMPOSITION: Medicinal substances in one lozenge: Dequalinum chloride 0.25 mg; Ascorbic acid 30 mg Excipients: glucose, saccharin sodium, pectin, vanillin, sucrose, cocoa, lactose monohydrate, magnesium stearate.
PHARMACEUTICAL FORM AND PACKAGING: Suction tablet, 20 pieces in PVC blisters / para. foil, 1 blister in a single cardboard box.
ACTION:
Efizol acts locally antiseptic, disrupts the development of various types of microorganisms, especially purulent causes, including some strains insensitive to antibiotics. It also has antifungal activity (candida, some epidermophytes and trichophytes). It destroys the causes of infections by affecting the formation of proteins, enzymes and damaging their cell membranes. Ascorbic acid (vitamin C) thickens the walls of blood vessels, reduces their permeability, the possibility of bleeding and edema. It has an anti-inflammatory effect.
INDICATIONS:
For topical antiseptic treatment of mild inflammatory processes in the oral cavity and throat caused by product-sensitive agents (catarrhal, ulcerative, fibrinous gingivitis, aphthous stomatitis, candidiasis, pharyngitis, tonsillitis, laryngitis and glossitis). infections before and postoperative interventions in the mouth and throat. In the complex treatment together with antibiotics or sulfonamides in more serious infections of the oropharynx.
CONTRAINDICATIONS: Hypersensitivity to the medicinal and / or excipients of the product
SPECIAL PRECAUTIONS FOR USE: Due to the lack of analgesic component in the product, its use is not appropriate in inflammatory processes accompanied by severe pain. In the presence of basic clinical symptoms, systemic antibacterial treatment is required for the spread of the infection. If any side effects occur, Efizol should be discontinued and another treatment given. Concomitant use with other topical products should be done with caution and at the discretion of the treating physician. Despite the low sugar content, the use of the product in diabetics should be done with caution in monitoring blood sugar levels. If there is no improvement or there is a worsening of symptoms, a doctor should be consulted.
DRUG AND OTHER INTERACTIONS: No data on drug and other interactions. Severe necrotic lesions of the skin and mucous membranes, especially in the gastrointestinal tract, are likely to occur when co-administered with Kayexalate (a product used in elevated blood potassium levels).
WARNINGS FOR SPECIAL GROUPS OF PATIENTS: The product is not suitable for children under 4 years of age due to the risk of the tablets getting into the airways.
APPLICATION FOR PREGNANT WOMEN AND BREASTFEEDING: Due to its low toxicity and lack of serious side effects, it can be prescribed during pregnancy and lactation.
EFFECTS ON ABILITY TO DRIVE AND USE MACHINES: No evidence of adverse effects on attention, concentration and motor reactions.
INFORMATION ON THE CORRECT USE OF THE MEDICINAL PRODUCT
DOSAGE AND METHOD OF ADMINISTRATION: Apply 1 lozenge every 2-3 hours (not more than 8-10 tablets in 24 hours). The tablets are not chewable. Half an hour after taking them, the patient needs to refrain from eating and drinking. It is recommended to continue treatment for 1-2 days after the symptoms of the disease subside. The total duration of treatment should not exceed 5-7 days (danger of disrupting the development of normal bacterial flora in the oral cavity and throat).
Overdose: There is no evidence of overdose with the product.
SIDE EFFECTS: The product is well tolerated, does not irritate tissues and no serious side effects have been reported. Rarely may cause nausea and vomiting; very rarely allergic reactions, burning and irritation or dryness in the oral cavity; disruption of the development of the normal bacterial flora in the oral cavity with prolonged use.
STORAGE: Store in a dry and protected from light place at a temperature below 25 ° С. Keep out of reach of children!
SHELF LIFE: 3 (three) years from the date of manufacture.
Manufacturer: ACTAVIS OTC
- Can be used by:Children
Women
Men - Beneficial effect on problems with:Respiratory system
Contacts
S. & S. TRIA ENNIARIA TRADING LTD
Please contact us via the form below.
Shipping
DELIVERY: |
||||
1. Receive your order from our shop in Nicosia: See map here: 12 а-b Naxou street here |
||||
2. Receiving from the" offices " of our couriers in Cyprus: - Akis Express view the offices here:
|
||||
3. Receiving your specified" address " in Cyprus: - Geniki Tachydromiki View the iffices here: - Akis Express |
||||
4. Receiving your "address" in Greece and Bulgaria: - Geniki Tachydromiki |
||||
5. Receiving your specified "address" in other than the countries listed above: - UPS - Courier |
||||
TIME LIMIT OF RECEIPT: |
||||
|
||||
* We are committed to packing and delivering your order in a well-protected package. |
||||
PRICES FOR DELIVERY AND PACKAGING |
||||
Prices for delivery and packaging "to Office" of couriers in Cyprus: |
||||
"To the Office" of Akis Express: for orders up to € 35, the fee is € 3.50 for orders over € 35, Free Shipping |
||||
|
||||
Prices for delivery and packaging "To Address" of couriers in Cyprus: |
||||
"To address" with Geniki Tachydromiki: for orders up to apostille 45, the fee is apostille 4.50 |
||||
"To address" with Akis Express: for orders up to apostille 45, the fee is apostille 4.50 for orders over € 45, Free Shipping |
||||
|
||||
*Upon request of the client for "cash on Delivery" an additional fee is charged from € 0.50 |
||||
|
||||
Prices for delivery and packaging "to address" of couriers in Greece and Bulgaria: |
||||
|
||||
|